Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 3:32 AM
Ignite Modification Date:
2025-12-25 @ 3:32 AM
NCT ID:
NCT06095505
Brief Title:
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Official Title:
A Phase 2 Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Acronym:
ALISCA-Lung1
Study:
NCT06095505
Protocol Section:
NCT06095505